Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Appl Microbiol ; 88: 57-101, 2014.
Article in English | MEDLINE | ID: mdl-24767426

ABSTRACT

Threonine aldolases catalyze the pyridoxal phosphate-dependent condensation between small amino acids (principally glycine) and aldehydes such as acetaldehyde. Carbon-carbon bond formation involves forming two adjacent chiral centers. As a rule, threonine aldolases are very stereoselective for α-carbon configuration but show modest selectivity at the ß-carbon. On the other hand, these enzymes accept a wide variety of synthetically useful acceptor aldehydes, making them important additions to the synthetic toolkit. This review briefly summarizes the reaction mechanism and then lists all published synthetic reactions by threonine aldolases as of early 2014. The current state of the art in crystallographic and protein engineering studies of these enzymes is also presented.


Subject(s)
Glycine Hydroxymethyltransferase/metabolism , Catalysis , Crystallography , Enzyme Stability , Glycine Hydroxymethyltransferase/chemistry , Protein Engineering
2.
Pediatr Res ; 65(3): 311-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19047917

ABSTRACT

As the incidence of cystic fibrosis (CF) bone disease is increasing, we analyzed CF transmembrane conductance regulator (CFTR) deficient mice (CF mice) to gain pathogenic insights. In these studies comparing adult (14 wk) CF and C57BL/6J mice, both bone length and total area were decreased in CF mice. Metaphyseal trabecular and cortical density were also decreased, as well as diaphyseal cortical and total density. Trabecular bone volume was diminished in CF mice. Female CF mice revealed decreased trabecular width and number compared with C57BL/6J, whereas males demonstrated no difference in trabecular number. Female CF mice had reduced mineralizing surface and bone formation rates. Conversely, male CF mice had increased mineralizing surface, mineral apposition, and bone formation rates compared with C57BL/6J males. Bone formation rate was greater in males compared with female CF mice. Smaller bones with decreased density in CF, despite absent differences in osteoblast and osteoclast surfaces, suggest CF transmembrane conductance regulator influences bone cell activity rather than number. Differences in bone formation rate in CF mice are suggestive of inadequate bone formation in females but increased bone formation in males. This proanabolic observation in male CF mice is consistent with other clinical sex differences in CF.


Subject(s)
Bone Diseases, Metabolic/etiology , Bone Diseases, Metabolic/pathology , Cystic Fibrosis/complications , Disease Models, Animal , Osteogenesis/physiology , Animals , Body Weights and Measures , Bone and Bones/pathology , Cystic Fibrosis Transmembrane Conductance Regulator/deficiency , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Sex Factors
3.
Am J Physiol Endocrinol Metab ; 295(5): E1213-22, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18780767

ABSTRACT

High-dose testosterone enanthate (TE) may prevent hypogonadism-induced osteopenia. For this study, 3-mo-old male and female Fisher SAS rats underwent sham surgery, gonadectomy (GX), or GX plus 28 days TE administration (7.0 mg/wk). GX reduced serum sex hormones (i.e., testosterone, dihydrotestosterone, and estradiol) (P < 0.05) in both sexes and bone concentrations of testosterone (males only), and estradiol (females only). GX also elevated urine deoxypyridinoline/creatinine in both sexes and serum osteocalcin (females only), findings that are consistent with high-turnover osteopenia. GX reduced cancellous bone volume (CBV) and increased osteoid surfaces in tibia of both sexes. GX males also experienced reduced trabecular number and width and increased trabecular separation, whereas GX females experienced increased osteoblast and osteoid surfaces. Bone biomechanical characteristics remained unaffected by GX, except that femoral stiffness was reduced in females. In contrast, TE administration to GX rats elevated serum and bone androgens to supraphysiological concentrations in both sexes but altered neither serum nor bone estradiol in males. Additionally, TE did not prevent GX-induced reductions in serum or bone estradiol in females. TE also reduced markers of high-turnover osteopenia in both sexes. In males, TE prevented GX-induced changes in trabecular number and separation, CBV, and osteoid surfaces while diminishing osteoblast and osteoclast surfaces; however, these changes were not fully prevented in females. In both sexes, TE increased femoral length and femoral maximal strength to above that of Sham and GX animals while preventing the loss of femoral stiffness in females. In conclusion, TE administration appears protective of cancellous bone in male rats and augments cortical bone strength in both sexes.


Subject(s)
Bone and Bones/drug effects , Orchiectomy , Osteoporosis/prevention & control , Ovariectomy , Testosterone/analogs & derivatives , Amino Acids/urine , Androgens/administration & dosage , Androgens/pharmacology , Androgens/therapeutic use , Animals , Body Weight/drug effects , Body Weight/physiology , Bone and Bones/metabolism , Creatinine/urine , Dihydrotestosterone/blood , Dihydrotestosterone/metabolism , Estradiol/blood , Estradiol/metabolism , Female , Femur/drug effects , Femur/pathology , Kidney/drug effects , Kidney/pathology , Male , Muscle, Skeletal/drug effects , Muscle, Skeletal/pathology , Organ Size/drug effects , Osteocalcin/blood , Osteoporosis/metabolism , Osteoporosis/pathology , Rats , Rats, Inbred F344 , Tensile Strength/drug effects , Testosterone/administration & dosage , Testosterone/blood , Testosterone/metabolism , Testosterone/pharmacology , Testosterone/therapeutic use , Tibia/drug effects , Tibia/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...